COMMUNIQUÉS West-GlobeNewswire

-
Intercept Announces Multiple New Ocaliva® (obeticholic acid) Data Presentations at the International Liver Congress™ 2018
23/03/2018 -
PLx Pharma Inc. Reports Fourth Quarter and Full Year 2017 Results
23/03/2018 -
Shire plc : District Court Issues Ruling Finding Adderall XR® Patents Infringed
23/03/2018 -
Accelerate Diagnostics, Inc. Announces Pricing of $150 Million Convertible Notes Offering
23/03/2018 -
Ozempic® approved in Japan for the treatment of type 2 diabetes
23/03/2018 -
UCB: CONVENING NOTICE TO ATTEND THE GENERAL MEETING OF SHAREHOLDERS TO BE HELD AT BLUEPOINT BRUSSELS
23/03/2018 -
UCB: CONVOCATION À L'ASSEMBLÉE GÉNÉRALE DES ACTIONNAIRES QUI SE TIENDRA À BLUEPOINT BRUSSELS
23/03/2018 -
INNATE PHARMA : Expansion of mCRC cohort in Phase I trial evaluating monalizumab with Imfinzi
23/03/2018 -
INNATE PHARMA : Extension de cohorte dans la Phase I évaluant monalizumab et Imfinzi dans le cancer colorectal
23/03/2018 -
Amicus Therapeutics Announces Approval of Galafold® (Migalastat) for Fabry Disease in Japan
23/03/2018 -
Updated TACTI-mel Data Presented at the Cambridge Healthtech Institute’s Immuno-Oncology Summit
23/03/2018 -
Phase III data in The Lancet show Novartis siponimod significantly improves outcomes in patients with secondary progressive MS
23/03/2018 -
CV Sciences, Inc. to Host Fourth Quarter and Year End 2017 Financial Results Conference Call on Thursday, March 29, 2018
23/03/2018 -
AFA: How Federal Spending Deal Impacts Individuals with Alzheimer’s
22/03/2018 -
Vistin Pharma ASA : Key information for the subsequent repair issue
22/03/2018 -
Vistin Pharma ASA : SUCCESSFULLY COMPLETED PRIVATE PLACEMENT
22/03/2018 -
Tergus Pharma announces the Acquisition of EnDev Labs
22/03/2018 -
Healthcare Special Opportunities Fund Announces NAV Correction
22/03/2018 -
iKang Announces Unaudited Financial Results for the Fiscal Third Quarter Ended December 31, 2017
22/03/2018
Pages